M.D. Anderson Cancer Center cancer data

Researchers from the M.D. Anderson Cancer Center and colleagues reported a retrospective analysis of the U.S. Phase III RTOG 0129 trial in 721 patients with stage III or IV oropharyngeal squamous cell...